Detalles de la búsqueda
1.
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis.
J Med Virol
; 95(2): e28452, 2023 02.
Artículo
Inglés
| MEDLINE | ID: mdl-36597900
2.
Incidence of post-transplant hepatitis B virus reactivation with the use of kidneys from donors with resolved hepatitis B virus infection.
J Viral Hepat
; 29(11): 976-985, 2022 11.
Artículo
Inglés
| MEDLINE | ID: mdl-36031873
3.
Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon-lambda 3 induction in chronic hepatitis B patients.
Hepatol Res
; 52(7): 586-596, 2022 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-35352445
4.
Overestimated renal function in patients with liver cirrhosis predicts poor prognosis.
Hepatol Res
; 52(7): 603-613, 2022 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-35352857
5.
The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.
Hepatol Res
; 52(6): 508-521, 2022 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-35129841
6.
Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling.
Carcinogenesis
; 42(1): 58-69, 2021 02 11.
Artículo
Inglés
| MEDLINE | ID: mdl-32449510
7.
Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass.
J Viral Hepat
; 28(5): 755-763, 2021 05.
Artículo
Inglés
| MEDLINE | ID: mdl-33587828
8.
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.
Hepatol Res
; 51(9): 979-989, 2021 Sep.
Artículo
Inglés
| MEDLINE | ID: mdl-34245216
9.
Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19.
Hepatol Res
; 50(10): 1196-1200, 2020 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-32729953
10.
Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people.
Hepatol Res
; 50(6): 715-725, 2020 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-32202371
11.
High serum angiopoietin-2 level predicts non-regression of liver stiffness measurement-based liver fibrosis stage after direct-acting antiviral therapy for hepatitis C.
Hepatol Res
; 50(6): 671-681, 2020 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-32020702
12.
Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria.
Hepatol Res
; 50(8): 966-977, 2020 Aug.
Artículo
Inglés
| MEDLINE | ID: mdl-32562334
13.
Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan.
J Gastroenterol Hepatol
; 35(10): 1782-1788, 2020 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-32187734
14.
Quantifying Protein-Specific N-Glycome Profiles by Focused Protein and Immunoprecipitation Glycomics.
J Proteome Res
; 18(8): 3133-3141, 2019 08 02.
Artículo
Inglés
| MEDLINE | ID: mdl-31266306
15.
Comparative Glycomic Analysis of Sialyl Linkage Isomers by Sialic Acid Linkage-Specific Alkylamidation in Combination with Stable Isotope Labeling of α2,3-Linked Sialic Acid Residues.
Anal Chem
; 91(21): 13343-13348, 2019 11 05.
Artículo
Inglés
| MEDLINE | ID: mdl-31577134
16.
Effects of resistance-associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs.
Hepatol Res
; 49(11): 1275-1285, 2019 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-31261439
17.
Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter.
Hepatol Res
; 49(10): 1207-1217, 2019 Oct.
Artículo
Inglés
| MEDLINE | ID: mdl-31219667
18.
Entecavir treatment of hepatitis B virus-infected patients with severe renal impairment and those on hemodialysis.
Hepatol Res
; 49(11): 1294-1304, 2019 Nov.
Artículo
Inglés
| MEDLINE | ID: mdl-31260579
19.
Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis.
Hepatol Res
; 48(3): E311-E319, 2018 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-28984014
20.
Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study.
Hepatol Res
; 48(3): E146-E154, 2018 Feb.
Artículo
Inglés
| MEDLINE | ID: mdl-28722780